Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuo Horikoshi is active.

Publication


Featured researches published by Nobuo Horikoshi.


Cancer Research | 2007

Hyperthermia Activates a Subset of Ataxia-Telangiectasia Mutated Effectors Independent of DNA Strand Breaks and Heat Shock Protein 70 Status

Clayton R. Hunt; Raj K. Pandita; Andrei Laszlo; Manjula Agarwal; Tetsuya Kitamura; Arun Gupta; Nicole Rief; Nobuo Horikoshi; Rajeskaran Baskaran; Ji-Hoon Lee; Markus Löbrich; Tanya T. Paull; Joseph L. Roti Roti; Tej K. Pandita

All cells have intricately coupled sensing and signaling mechanisms that regulate the cellular outcome following exposure to genotoxic agents such as ionizing radiation (IR). In the IR-induced signaling pathway, specific protein events, such as ataxia-telangiectasia mutated protein (ATM) activation and histone H2AX phosphorylation (gamma-H2AX), are mechanistically well characterized. How these mechanisms can be altered, especially by clinically relevant agents, is not clear. Here we show that hyperthermia, an effective radiosensitizer, can induce several steps associated with IR signaling in cells. Hyperthermia induces gamma-H2AX foci formation similar to foci formed in response to IR exposure, and heat-induced gamma-H2AX foci formation is dependent on ATM but independent of heat shock protein 70 expression. Hyperthermia also enhanced ATM kinase activity and increased cellular ATM autophosphorylation. The hyperthermia-induced increase in ATM phosphorylation was independent of Mre11 function. Similar to IR, hyperthermia also induced MDC1 foci formation; however, it did not induce all of the characteristic signals associated with irradiation because formation of 53BP1 and SMC1 foci was not observed in heated cells but occurred in irradiated cells. Additionally, induction of chromosomal DNA strand breaks was observed in IR-exposed but not in heated cells. These results indicate that hyperthermia activates signaling pathways that overlap with those activated by IR-induced DNA damage. Moreover, prior activation of ATM or other components of the IR-induced signaling pathway by heat may interfere with the normal IR-induced signaling required for chromosomal DNA double-strand break repair, thus resulting in increased cellular radiosensitivity.


Circulation Research | 2008

Identification of Cardiac-Specific Myosin Light Chain Kinase

Jason Y. F. Chan; Morihiko Takeda; Laura E. Briggs; Megan L. Graham; Jonathan Lu; Nobuo Horikoshi; Ellen O. Weinberg; Hiroki Aoki; Naruki Sato; Kenneth R. Chien; Hideko Kasahara

Two myosin light chain (MLC) kinase (MLCK) proteins, smooth muscle (encoded by mylk1 gene) and skeletal (encoded by mylk2 gene) MLCK, have been shown to be expressed in mammals. Even though phosphorylation of its putative substrate, MLC2, is recognized as a key regulator of cardiac contraction, a MLCK that is preferentially expressed in cardiac muscle has not yet been identified. In this study, we characterized a new kinase encoded by a gene homologous to mylk1 and -2, named cardiac MLCK, which is specifically expressed in the heart in both atrium and ventricle. In fact, expression of cardiac MLCK is highly regulated by the cardiac homeobox protein Nkx2-5 in neonatal cardiomyocytes. The overall structure of cardiac MLCK protein is conserved with skeletal and smooth muscle MLCK; however, the amino terminus is quite unique, without significant homology to other known proteins, and its catalytic activity does not appear to be regulated by Ca2+/calmodulin in vitro. Cardiac MLCK is phosphorylated and the level of phosphorylation is increased by phenylephrine stimulation accompanied by increased level of MLC2v phosphorylation. Both overexpression and knockdown of cardiac MLCK in cultured cardiomyocytes revealed that cardiac MLCK is likely a new regulator of MLC2 phosphorylation, sarcomere organization, and cardiomyocyte contraction.


Journal of Biological Chemistry | 2001

Characterization of Homo- and Heterodimerization of Cardiac Csx/Nkx2.5 Homeoprotein

Hideko Kasahara; Anny Usheva; Tomomi Ueyama; Hiroki Aoki; Nobuo Horikoshi; Seigo Izumo

Csx/Nkx2.5 is an evolutionarily conserved homeodomain (HD)-containing transcription factor that is essential for early cardiac development. We found that the HD of Csx/Nkx2.5 binds as a monomer as well as a dimer to its DNA binding sites in the promoter of the atrial natriuretic factor (ANF) gene, an in vivotarget gene of Csx/Nkx2.5. Csx/Nkx2.5 physically interacts with each other in vitro as well as in cells, and the HD is critical for homodimerization. Lys193 and Arg194, located at the COOH-terminal end of HD, are essential for dimerization. Lys193 is also required for a specific interaction with the zinc finger transcription factor GATA4. Csx/Nkx2.5 can heterodimerize with other NK2 homeodomain proteins, Nkx2.3 and Nkx2.6/Tix, with different affinities. A single missense mutation, Ile183 to Pro in the HD of Csx/Nkx2.5, preserved homodimerization function, but totally abolished DNA binding. Ile183 → Pro mutant acts in an inhibitory manner on wild type Csx/Nkx2.5 transcriptional activity through the ANF promoter in 10T1/2 cells. However, Ile183 → Pro mutant does not inhibit wild type Csx/Nkx2.5 function on the ANF promoter in cultured neonatal cardiac myocytes, possibly due to failure of dimerization in the presence of the target DNA. These results suggest that complex protein-protein interactions of Csx/Nkx2.5 play a role in its transcriptional regulatory function.


Circulation Research | 2008

Perinatal Loss of Nkx2-5 Results in Rapid Conduction and Contraction Defects

Laura E. Briggs; Morihiko Takeda; Adolfo E. Cuadra; Hiroko Wakimoto; Melissa H. Marks; Alexandra J. Walker; Tsugio Seki; Suk Paul Oh; Jonathan Lu; Colin Sumners; Mohan K. Raizada; Nobuo Horikoshi; Ellen O. Weinberg; Kenji Yasui; Yasuhiro Ikeda; Kenneth R. Chien; Hideko Kasahara

Homeobox transcription factor Nkx2-5, highly expressed in heart, is a critical factor during early embryonic cardiac development. In this study, using tamoxifen-inducible Nkx2-5 knockout mice, we demonstrate the role of Nkx2-5 in conduction and contraction in neonates within 4 days after perinatal tamoxifen injection. Conduction defect was accompanied by reduction in ventricular expression of the cardiac voltage-gated Na+ channel pore-forming &agr;-subunit (Nav1.5-&agr;), the largest ion channel in the heart responsive for rapid depolarization of the action potential, which leads to increased intracellular Ca2+ for contraction (conduction–contraction coupling). In addition, expression of ryanodine receptor 2, through which Ca2+ is released from sarcoplasmic reticulum, was substantially reduced in Nkx2-5 knockout mice. These results indicate that Nkx2-5 function is critical not only during cardiac development but also in perinatal hearts, by regulating expression of several important gene products involved in conduction and contraction.


Radiation Research | 2013

Histone Modifications and DNA Double-Strand Break Repair after Exposure to Ionizing Radiations

Clayton R. Hunt; Deepti B. Ramnarain; Nobuo Horikoshi; Puneeth Iyengar; Raj K. Pandita; Jerry W. Shay; Tej K. Pandita

Ionizing radiation exposure induces highly lethal DNA double-strand breaks (DSBs) in all phases of the cell cycle. After DSBs are detected by the cellular machinery, these breaks are repaired by either of two mechanisms: (1) nonhomologous end joining (NHEJ), which re-ligates the broken ends of the DNA and (2) homologous recombination (HR), that makes use of an undamaged identical DNA sequence as a template to maintain the fidelity of DNA repair. DNA DSB repair must occur within the context of the natural cellular DNA structure. Among the major factors influencing DNA organization are specific histone and nonhistone proteins that form chromatin. The overall chromatin structure regulates DNA damage responses since chromatin status can impede DNA damage site access by repair proteins. During the process of DNA DSB repair, several chromatin alterations are required to sense damage and facilitate accessibility of the repair machinery. The DNA DSB response is also facilitated by hierarchical signaling networks that orchestrate chromatin structural changes that may coordinate cell-cycle checkpoints involving multiple enzymatic activities to repair broken DNA ends. During DNA damage sensing and repair, histones undergo posttranslational modifications (PTMs) including phosphorylation, acetylation, methylation and ubiquitylation. Such histone modifications represent a histone code that directs the recruitment of proteins involved in DNA damage sensing and repair processes. In this review, we summarize histone modifications that occur during DNA DSB repair processes.


FEBS Letters | 2002

A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).

Yoichi Ohiro; Igor Garkavtsev; Shinichiro Kobayashi; Kodangattil R. Sreekumar; Regan Nantz; Bryan T. Higashikubo; Shannon L. Duffy; Anny Usheva; David Gius; Nikolai Kley; Nobuo Horikoshi

The p53 tumor suppressor protein induces cell cycle arrest or apoptosis in response to cellular stresses. We have identified PRG3 ( 53‐ esponsive ene 3), which is induced specifically under p53‐dependent apoptotic conditions in human colon cancer cells, and encodes a novel polypeptide of 373 amino acids with a predicted molecular mass of 40.5 kDa. PRG3 has significant homology to bacterial oxidoreductases and the apoptosis‐inducing factor, AIF, and the gene was assigned to chromosome 10q21.3–q22.1. Expression of PRG3 was induced by the activation of endogenous p53 and it contains a p53‐responsive element. Unlike AIF, PRG3 localizes in the cytoplasm and its ectopic expression induces apoptosis. An amino‐terminal deletion mutant of PRG3 that lacks a putative oxidoreductase activity retains its apoptotic activity, suggesting that the oxidoreductase activity is dispensable for the apoptotic function of PRG3. The PRG3 gene is thus a novel p53 target gene in a p53‐dependent apoptosis pathway.


Cell Reports | 2014

MOF Phosphorylation by ATM Regulates 53BP1-Mediated Double-Strand Break Repair Pathway Choice

Arun Gupta; Clayton R. Hunt; Muralidhar L. Hegde; Sharmistha Chakraborty; Durga Udayakumar; Nobuo Horikoshi; Mayank Singh; Deepti B. Ramnarain; Walter N. Hittelman; Sarita Namjoshi; Aroumougame Asaithamby; Tapas K. Hazra; Thomas Ludwig; Raj K. Pandita; Jessica K. Tyler; Tej K. Pandita

Cell-cycle phase is a critical determinant of the choice between DNA damage repair by nonhomologous end-joining (NHEJ) or homologous recombination (HR). Here, we report that double-strand breaks (DSBs) induce ATM-dependent MOF (a histone H4 acetyl-transferase) phosphorylation (p-T392-MOF) and that phosphorylated MOF colocalizes with γ-H2AX, ATM, and 53BP1 foci. Mutation of the phosphorylation site (MOF-T392A) impedes DNA repair in S and G2 phase but not G1 phase cells. Expression of MOF-T392A also blocks the reduction in DSB-associated 53BP1 seen in wild-type S/G2 phase cells, resulting in enhanced 53BP1 and reduced BRCA1 association. Decreased BRCA1 levels at DSB sites correlates with defective repairosome formation, reduced HR repair, and decreased cell survival following irradiation. These data support a model whereby ATM-mediated MOF-T392 phosphorylation modulates 53BP1 function to facilitate the subsequent recruitment of HR repair proteins, uncovering a regulatory role for MOF in DSB repair pathway choice during S/G2 phase.


Molecular and Cellular Biology | 2013

Lamin A/C depletion enhances DNA damage-induced stalled replication fork arrest

Mayank Singh; Clayton R. Hunt; Raj K. Pandita; Rakesh K. Kumar; Chin Rang Yang; Nobuo Horikoshi; Robert M. Bachoo; Sara Serag; Michael D. Story; Jerry W. Shay; Simon N. Powell; Arun Gupta; Jessie Jeffery; Shruti Pandita; Benjamin P C Chen; Dorothee Deckbar; Markus Löbrich; Qin Yang; Kum Kum Khanna; Howard J. Worman; Tej K. Pandita

The human LMNA gene encodes the essential nuclear envelope proteins lamin A and C (lamin A/C). Mutations in LMNA result in altered nuclear morphology, but how this impacts the mechanisms that maintain genomic stability is unclear. Here, we report that lamin A/C-deficient cells have a normal response to ionizing radiation but are sensitive to agents that cause interstrand cross-links (ICLs) or replication stress. In response to treatment with ICL agents (cisplatin, camptothecin, and mitomycin), lamin A/C-deficient cells displayed normal γ-H2AX focus formation but a higher frequency of cells with delayed γ-H2AX removal, decreased recruitment of the FANCD2 repair factor, and a higher frequency of chromosome aberrations. Similarly, following hydroxyurea-induced replication stress, lamin A/C-deficient cells had an increased frequency of cells with delayed disappearance of γ-H2AX foci and defective repair factor recruitment (Mre11, CtIP, Rad51, RPA, and FANCD2). Replicative stress also resulted in a higher frequency of chromosomal aberrations as well as defective replication restart. Taken together, the data can be interpreted to suggest that lamin A/C has a role in the restart of stalled replication forks, a prerequisite for initiation of DNA damage repair by the homologous recombination pathway, which is intact in lamin A/C-deficient cells. We propose that lamin A/C is required for maintaining genomic stability following replication fork stalling, induced by either ICL damage or replicative stress, in order to facilitate fork regression prior to DNA damage repair.


Radiation Research | 2014

Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice

Arun Gupta; Clayton R. Hunt; Sharmistha Chakraborty; Raj K. Pandita; John S. Yordy; Deepti B. Ramnarain; Nobuo Horikoshi; Tej K. Pandita

The p53-binding protein 1 (53BP1) is a well-known DNA damage response (DDR) factor, which is recruited to nuclear structures at the site of DNA damage and forms readily visualized ionizing radiation (IR) induced foci. Depletion of 53BP1 results in cell cycle arrest in G2/M phase as well as genomic instability in human as well as mouse cells. Within the DNA damage response mechanism, 53BP1 is classified as an adaptor/mediator, required for processing of the DNA damage response signal and as a platform for recruitment of other repair factors. More recently, specific 53BP1 contributions to DSB repair pathway choice have been recognized and are being characterized. In this review, we have summarized recent advances in understanding the role of 53BP1 in regulating DNA DSBs repair pathway choice, variable diversity joining [V(D)J] recombination and class-switch recombination (CSR).


Cancer Research | 2007

Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway.

Konjeti R. Sekhar; Vijayakumar N. Sonar; Venkatraj Muthusamy; Soumya Sasi; Andrei Laszlo; Jamil Sawani; Nobuo Horikoshi; Robert G. Bristow; Michael J. Borrelli; Peter A. Crooks; James R. Lepock; Joseph L. Roti Roti

Radiation therapy combined with adjuvant hyperthermia has the potential to provide outstanding local-regional control for refractory disease. However, achieving therapeutic thermal dose can be problematic. In the current investigation, we used a chemistry-driven approach with the goal of designing and synthesizing novel small molecules that could function as thermal radiosensitizers. (Z)-(+/-)-2-(1-Benzenesulfonylindol-3-ylmethylene)-1-azabicyclo[2.2.2]octan-3-ol was identified as a compound that could lower the threshold for Hsf1 activation and thermal sensitivity. Enhanced thermal sensitivity was associated with significant thermal radiosensitization. We established the structural requirements for activity: the presence of an N-benzenesulfonylindole or N-benzylindole moiety linked at the indolic 3-position to a 2-(1-azabicyclo[2.2.2]octan-3-ol) or 2-(1-azabicyclo[2.2.2]octan-3-one) moiety. These small molecules functioned by exploiting the underlying biophysical events responsible for thermal sensitization. Thermal radiosensitization was characterized biochemically and found to include loss of mitochondrial membrane potential, followed by mitotic catastrophe. These studies identified a novel series of small molecules that represent a promising tool for the treatment of recurrent tumors by ionizing radiation.

Collaboration


Dive into the Nobuo Horikoshi's collaboration.

Top Co-Authors

Avatar

Tej K. Pandita

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar

Clayton R. Hunt

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar

Raj K. Pandita

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar

Anny Usheva

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar

Arun Gupta

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Kalpana Mujoo

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Yayoi Fukuyo

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

David Gius

Northwestern University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mayank Singh

University of Texas Southwestern Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge